“Radioligand Therapy Beyond Neuroendocrine Tumours: Dosimetry, Supply Chain and Access”. Translational Medicine & Therapeutics Journal, vol. 2, no. 2, Aug. 2023, pp. 64-73, https://doi.org/10.5281/zenodo.22649084.